Vendel K.
- Country
- Norway
- Department
- Gastorenterology
Research Overview
- Efficacy and Safety Evaluation of Oral Zasocitinib in Patients with Moderately to Severely Active Crohn's Disease: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety of Oral Zasocitinib in Moderate to Severe Ulcerative Colitis: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
- Long-term Safety and Tolerability Evaluation of Oral Zasocitinib in Moderate to Severe Ulcerative Colitis and Crohn's Disease Patients
Data & Insights
Has run more than one trial at 86 of 107 partner sites.
Specializations
Inflammatory Bowel Disease Research
This investigator specializes in treating inflammatory bowel diseases, with particular focus on ulcerative colitis and Crohn's disease. Their research encompasses both moderate and severe manifestations of these conditions.
- Moderate to Severe Ulcerative Colitis
- Moderate to Severe Crohn's Disease
Their work involves evaluating novel therapeutic approaches for managing these chronic inflammatory conditions.
Therapeutic Innovation
The investigator's research focuses on developing oral treatment modalities for inflammatory bowel conditions, particularly exploring new therapeutic compounds for long-term disease management.
- Novel Oral Therapeutics
- Long-term Treatment Strategies
- Clinical Remission Studies
Their work emphasizes evaluating treatment efficacy and safety in chronic gastrointestinal conditions.
Clinical Outcomes
The investigator specializes in assessing clinical remission and endoscopic response in patients with inflammatory bowel conditions. Their research examines both short-term and extended treatment outcomes.
- Treatment Response Assessment
- Disease Activity Monitoring
- Long-term Safety Evaluation
Their studies focus on measuring therapeutic effectiveness through multiple clinical parameters.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.